Conduit Pharmaceuticals Stock (NASDAQ: CDT) stock price, news, charts, stock research, profile.
Open | $3.050 |
Close | $3.170 |
Volume / Avg. | 5.588K / 32.497K |
Day Range | 3.050 - 3.170 |
52 Wk Range | 0.950 - 12.890 |
Market Cap | $231.086M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | - |
Days to Cover | 1.48 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Conduit Pharmaceuticals (NASDAQ: CDT) through any online brokerage.
Other companies in Conduit Pharmaceuticals’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Lifecore Biomedical (NASDAQ:LFCR) and Quanterix (NASDAQ:QTRX).
There is no analysis for Conduit Pharmaceuticals.
The stock price for Conduit Pharmaceuticals (NASDAQ: CDT) is $3.13 last updated April 5, 2024 at 7:32 PM EDT.
There are no upcoming dividends for Conduit Pharmaceuticals.
Conduit Pharmaceuticals’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Conduit Pharmaceuticals.
Conduit Pharmaceuticals is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.